Valuation: Hofseth BioCare ASA

Market Cap 687M 71.86M 62.36M 58.39M 53.42M 101M 6.85B 102M 683M 268M 3.42B 270M 264M 11.38B P/E 2024
-5.58x
P/E 2025 -4x
Enterprise Value 980M 103M 88.96M 83.3M 76.2M 144M 9.77B 146M 975M 382M 4.88B 385M 377M 16.24B EV / Sales 2024
3.18x
EV / Sales 2025 3.26x
Free-Float
68.38%
Yield 2024 *
-
Yield 2025 -
1 day+0.38%
1 week+0.38%
Current month-2.22%
1 month-7.37%
3 months+1.54%
6 months-6.71%
1 week 1.22
Extreme 1.22
1.4
1 month 1.22
Extreme 1.22
1.74
Current year 1.1
Extreme 1.1
2.01
1 year 1.1
Extreme 1.1
2.42
3 years 1.1
Extreme 1.1
3.6
5 years 1.1
Extreme 1.1
8
10 years 1.1
Extreme 1.1
10.95
Manager TitleAgeSince
Chief Executive Officer 53 01/08/2022
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer 65 01/01/2010
Director TitleAgeSince
Director/Board Member 55 01/05/2015
Director/Board Member - -
Director/Board Member - 03/12/2021
Date Insider Type Main position Quantity % Market Cap.
7/14/23 A Buy 74,000 0.0187%
2/28/23 A Buy

Chief Technology Officer

200,000 0.0506%
2/17/23 A Buy

Director

100,000 0.0253%
Change 5-day change 1-year change 3-year change Capi.($)
+0.38%+0.38%-25.00%-55.85% 72.14M
-0.28%-1.53%+13.68%-22.27% 259B
+0.14%-0.78%+0.84%-15.72% 79.9B
+0.24%-0.26%-5.04%+25.13% 50.51B
+0.03%+0.02%+141.52%+520.51% 45.2B
-0.02%-3.88%+36.58%-11.16% 37.39B
+1.05%+2.33%-3.84%-20.76% 36.08B
-2.57%+7.20%+32.89%+88.33% 32.31B
-1.38%+0.08%+32.33%+33.57% 30.85B
-2.62%-5.53%-8.58%-28.80% 30.51B
Average -0.48%-0.42%+21.54%+51.30% 60.2B
Weighted average by Cap. -0.26%-1.53%+21.23%+32.57%

Financials

2024 2025
Net sales 266M 27.79M 24.11M 22.58M 20.65M 38.99M 2.65B 39.5M 264M 104M 1.32B 104M 102M 4.4B 256M 26.82M 23.28M 21.8M 19.94M 37.64M 2.56B 38.13M 255M 100M 1.28B 101M 98.53M 4.25B
Net income -125M -13.11M -11.38M -10.65M -9.75M -18.4M -1.25B -18.64M -125M -48.92M -624M -49.23M -48.16M -2.08B -135M -14.11M -12.25M -11.47M -10.49M -19.81M -1.34B -20.06M -134M -52.66M -672M -52.99M -51.84M -2.24B
Net Debt 145M 15.2M 13.19M 12.36M 11.3M 21.34M 1.45B 21.62M 145M 56.73M 724M 57.09M 55.85M 2.41B 293M 30.65M 26.6M 24.9M 22.78M 43.01M 2.92B 43.57M 291M 114M 1.46B 115M 113M 4.86B
Logo Hofseth BioCare ASA
Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
Employees
81
Date Price Change Volume
06/08/26 NOK 1.320 +0.38% 11,942
05/08/26 NOK 1.315 -2.23% 36,018
04/08/26 NOK 1.345 +2.28% 108,354
03/08/26 NOK 1.315 -2.59% 62,894
31/07/26 NOK 1.350 +2.66% 453,442